Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farshid Oruji

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Discover Oncology|July 15, 2026
Anti-proliferation effects of oxaliplatin in combination with the probiotic Lactobacillus acidophilus in colorectal cancer cellsSaba Hajazimian, Alireza Isazadeh, Farshid Oruji, et al.
Molecular Biology Reports|September 23, 2023
Advances in siRNA delivery approaches in cancer therapy: challenges and opportunitiesHouman Isazadeh, Farshid Oruji, Shima Shabani, et al.
Molecular Biology Reports|October 31, 2023
Gingival mesenchymal stem cell therapy, immune cells, and immunoinflammatory applicationAmir Ebrahimpour Tolouei, Farshid Oruji, Sahar Tehrani, et al.
Pathology, Research and Practice|May 31, 2023
Cytokine sustained delivery for cancer therapy; special focus on stem cell- and biomaterial- based delivery methodsHossein Mehralizadeh, Ahmad Nazari, Farshid Oruji, et al.
Discover Oncology|May 31, 2026
Small interfering RNA (siRNA)-based targeting breast cancer therapyAmin Talebi, Afshin Khorrami, Farshid Oruji, et al.
Discover Oncology|October 15, 2025
Blood expression of CTLA-4, PD-1, and PD-L1 as potential prognostic and diagnostic markers for breast cancer: a systematic reviewMina Niusha, Saba Hajazimian, Nayemeh Soltani, et al.
Iranian Journal of Pharmaceutical Research : IJPR|December 14, 2021
Evaluation of Inflammasome Activation in Peripheral Blood Mononuclear Cells of Hemodialysis Treated Patients with GlomerulonephritisAtieh Hashemi, Razieh Bigdeli, Masoumeh Shahnazari, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysisMohsin Raza, Asher Rajkumar Rajan, Benjamin B Kennedy, et al.
Oncogene|September 4, 2025
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysisMohsin Raza, Asher Rajkumar Rajan, Benjamin B Kennedy, et al.
Cancer Letters|July 30, 2025
ECD co-operates with ERBB2 to promote tumorigenesis through upregulation of unfolded protein response and glycolysisBenjamin B Kennedy, Mohsin Raza, Sameer Mirza, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Discover Oncology|July 15, 2026
Anti-proliferation effects of oxaliplatin in combination with the probiotic Lactobacillus acidophilus in colorectal cancer cellsSaba Hajazimian, Alireza Isazadeh, Farshid Oruji, et al.
Molecular Biology Reports|September 23, 2023
Advances in siRNA delivery approaches in cancer therapy: challenges and opportunitiesHouman Isazadeh, Farshid Oruji, Shima Shabani, et al.
Molecular Biology Reports|October 31, 2023
Gingival mesenchymal stem cell therapy, immune cells, and immunoinflammatory applicationAmir Ebrahimpour Tolouei, Farshid Oruji, Sahar Tehrani, et al.
Pathology, Research and Practice|May 31, 2023
Cytokine sustained delivery for cancer therapy; special focus on stem cell- and biomaterial- based delivery methodsHossein Mehralizadeh, Ahmad Nazari, Farshid Oruji, et al.
Discover Oncology|May 31, 2026
Small interfering RNA (siRNA)-based targeting breast cancer therapyAmin Talebi, Afshin Khorrami, Farshid Oruji, et al.
Discover Oncology|October 15, 2025
Blood expression of CTLA-4, PD-1, and PD-L1 as potential prognostic and diagnostic markers for breast cancer: a systematic reviewMina Niusha, Saba Hajazimian, Nayemeh Soltani, et al.
Iranian Journal of Pharmaceutical Research : IJPR|December 14, 2021
Evaluation of Inflammasome Activation in Peripheral Blood Mononuclear Cells of Hemodialysis Treated Patients with GlomerulonephritisAtieh Hashemi, Razieh Bigdeli, Masoumeh Shahnazari, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysisMohsin Raza, Asher Rajkumar Rajan, Benjamin B Kennedy, et al.
Oncogene|September 4, 2025
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysisMohsin Raza, Asher Rajkumar Rajan, Benjamin B Kennedy, et al.
Cancer Letters|July 30, 2025
ECD co-operates with ERBB2 to promote tumorigenesis through upregulation of unfolded protein response and glycolysisBenjamin B Kennedy, Mohsin Raza, Sameer Mirza, et al.
Pageof 2